Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Other Non-Current Liabilities (2010 - 2024)

Updated

Bioxytran (BIXT) recorded Other Non-Current Liabilities of $186,652 in Q4 2024.

Analysis

Bioxytran (BIXT) Other Non-Current Liabilities (2010 - 2024) Analysis & Trends

  • The Q4 2024 figure is the lowest quarterly Other Non-Current Liabilities since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Bioxytran 2.29 Mn 1.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 186,652.00
Mar 31, 2022 1,155.00
Dec 31, 2010 2,132.00
API Access

Bioxytran Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BIXT&period=max&api_key=YOUR_API_KEY